Paul K. Laikind
11Patents
7h-index
10Co-inventors
52Inventor score
Filing activity: Oct 12, 1993 → Jun 7, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5716826A | Recombinant retroviruses | Chemistry; Metallurgy | 51 | Expired |
| US5716613A | Recombinant retroviruses | Chemistry; Metallurgy | 50 | Expired |
| US5691177A | Recombinant retroviruses expressing a protein that converts a pro-drug into a cytotoxic agent | Chemistry; Metallurgy | 47 | Expired |
| US5851529A | Recombinant retroviruses | Chemistry; Metallurgy | 35 | Expired |
| US5888502A | Recombinant retroviruses | Chemistry; Metallurgy | 16 | Expired |
| US6133029A | Replication defective viral vectors for infecting human cells | Chemistry; Metallurgy | 12 | Expired |
| US5817640A | Methods of preventing tissue damage associated with decreased blood flow by administration of AICA riboside compounds | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5830458A | Method for destroying a diseased human cell | Chemistry; Metallurgy | 6 | Expired |
| US5856185A | Method for making reflection defective retroviral vectors for infecting human cells | Chemistry; Metallurgy | 5 | Expired |
| US6410326B1 | Method for inhibiting human tumor cells | Chemistry; Metallurgy | 3 | Expired |
| US6495349B1 | Chimeric gene constructs | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.